<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">916</article-id><article-id pub-id-type="doi">10.31857/S102872210002432-0</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Effects of influences of recombinant IFNα2b on the level of expression of the CD16, CD66b, CD33, CD11b receptors of neutrophilic granulocytes of conditionally healthy children in the experiment in vitro</article-title><trans-title-group xml:lang="ru"><trans-title>Эффекты влияний рекомбинантного IFNα2b на уровень экспрессии CD16, CD66b, CD33, CD11b рецепторов нейтрофильных гранулоцитов условно-здоровых детей в эксперименте in vitro</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chudilova</surname><given-names>G. .</given-names></name><name xml:lang="ru"><surname>Чудилова</surname><given-names>Г. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nesterova</surname><given-names>I. .</given-names></name><name xml:lang="ru"><surname>Нестерова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rusinova</surname><given-names>T. .</given-names></name><name xml:lang="ru"><surname>Русинова</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kovaleva</surname><given-names>S. .</given-names></name><name xml:lang="ru"><surname>Ковалева</surname><given-names>С. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lomtatidze</surname><given-names>L. .</given-names></name><name xml:lang="ru"><surname>Ломтатидзе</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tarakanov</surname><given-names>V. .</given-names></name><name xml:lang="ru"><surname>Тараканов</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Verevkina</surname><given-names>V. .</given-names></name><name xml:lang="ru"><surname>Веревкина</surname><given-names>В. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlenko</surname><given-names>V. .</given-names></name><name xml:lang="ru"><surname>Павленко</surname><given-names>В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kuban State Medical University</institution></aff><aff><institution xml:lang="ru">Кубанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2018</year></pub-date><volume>21</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>486</fpage><lpage>492</lpage><history><date date-type="received" iso-8601-date="2020-10-22"><day>22</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Chudilova G..., Nesterova I..., Rusinova T..., Kovaleva S..., Lomtatidze L..., Tarakanov V..., Verevkina V..., Pavlenko V...</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Чудилова Г.А., Нестерова И.В., Русинова Т.В., Ковалева С.В., Ломтатидзе Л.В., Тараканов В.А., Веревкина В.С., Павленко В.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Chudilova G..., Nesterova I..., Rusinova T..., Kovaleva S..., Lomtatidze L..., Tarakanov V..., Verevkina V..., Pavlenko V...</copyright-holder><copyright-holder xml:lang="ru">Чудилова Г.А., Нестерова И.В., Русинова Т.В., Ковалева С.В., Ломтатидзе Л.В., Тараканов В.А., Веревкина В.С., Павленко В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/916">https://rusimmun.ru/jour/article/view/916</self-uri><abstract xml:lang="en"><p>The polyfunctionality of neutrophilic granulocytes (NG) is the result of the rich equipment of NGs by structures that respond subtly to changes in the extracellular environment and intracellular processes. At the present time there is a wave of publications that note the importance of the full participation of NG in the cascade of immunological reactions. Wherein the authors assign a key role to NG, both at the start-up and subsequent regulation and realization of the immune response. The existence of diff erent populations of NGs diff ering in the profi le of equipping with membrane antigens and exhibiting various functional possibilities is shown. The aim of this study was to study the eff ects of recombinant IFNα2b (rIFNα2b) on a non-transformed and experimentally transformed subpopulation CD16+CD66b+CD33+CD11b+NG in vitro of peripheral blood samples of conditionally healthy children. The expression level of the membrane NG receptors was determined by fl ow cytometry. The studied indicators of untransformed NG (control) and NG after incubation with rIFNα2b and N-formyl-methionyl-leucyl-phenylalanine (fMLP) were assessed. The immunoregulatory eff ect of rIFNα2b on the nontransformed phenotype CD16+CD66b+CD33+CD11b+NG and the immunomodulatory eff ects of rIFNα2b on the fMLP-transformed NG phenotype of peripheral blood of conditionally healthy children were established.</p></abstract><trans-abstract xml:lang="ru"><p>Полифункциональность нейтрофильных гранулоцитов (НГ) является результатом богатой экипировки НГ структурами, тонко реагирующими на изменения экстрацеллюлярного окружения и внутриклеточных процессов. В настоящее время идет волна публикаций, отмечающих важность полноценного участия НГ в каскаде иммунологических реакций. При этом авторы отводят ключевую роль именно НГ как при запуске, так и последующей регуляции и реализации иммунного ответа. Показано существование различных популяций НГ, отличающихся по профилю оснащения мембранными антигенами и проявляющих различные фукциональные возможности. Целью настоящего исследования явилось изучение влияний рекомбинантного ИФНα2b (rIFNα2b) на нетрансформированную и экспериментально трансформированную в системе in vitro CD16+CD66b+CD33+CD11b+ субпопуляцию НГ в образцах периферической крови ус лов но-здо ро вых детей. Уровень экспрессии мембранных рецепторов НГ определяли методом проточной цитометрии. Проведена оценка изучаемых показателей нетрансформированных НГ (контроль) и НГ после инкубации с rIFNα2b и N-формил-метионил-лейцил-фенилаланином (fMLP). Установлено иммунорегуляторное влияние rIFNα2b на нетрансформированный фенотип CD16+CD66b+CD33+CD11b+НГ и иммуномодулирующие эффекты rIFNα2b в отношении fMLP-трансформированного фенотипа НГ периферической крови условно-здоровых детей.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>neutrophilic granulocyte</kwd><kwd>recombinant rIFNα2b</kwd><kwd>phenotype</kwd><kwd>receptor</kwd><kwd>нейтрофильные гранулоциты</kwd><kwd>фенотип</kwd><kwd>рекомбинантный интерферон</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Scapini P., Marini O., Tecchio C., Cassatella M. A. Human neutrophils in the saga of cellular heterogeneity: insights and open questions. Immunol. Rev. 2016, 273(1) 48–60. DOI: 10.1111/imr.12448.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kobayashi Y. Neutrophil biology: an update. EXCLI J. 2015, 14, 220–227. DOI: 10.17179/excli2015–102.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Нестерова И. В., Колесникова Н. В., Чудилова Г. А., Ломтатидзе Л. В., Ковалева С. В., Евглевский А. А., Нгуен Т. З.Л. Новый взгляд на нейтрофильные гранулоциты: переосмысление старых догм. (Часть 1). Инфекция и Иммунитет 2017, 7(3), 219– 230. DOI:10.15789/2220–7619–2017–3–219–230. [Nesterova I. V., Kolesnikova N. V., Chudilova G. A., Lomtatidze L. V., Kovaleva S. V., Yevglevsky A. A., Nguyen T. Z.L. A new look at neutrophilic granulocytes: rethinking old dogmas. (Part 1). Infection and immunity 2017, 7(3), 219–230. DOI:10.15789/2220–7619–2017–3–219–230. Russian].</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Garley M., Jablonska E. Heterogeneity among neutrophils. Arch. Immunol. Ther. Exp. (Warsz). 2018, 66(1), 21–30. DOI: 10.1007/s00005–017–0476–4.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Нестерова И. В., Колесникова Н. В., Чудилова Г. А., Ломтатидзе Л. В., Ковалева С. В., Евглевский А. А., Нгуен Т. З.Л. Новый взгляд на нейтрофильные гранулоциты: переосмысление старых догм. (Часть 2). Инфекция и иммунитет 2018, 8(1), 7–18. DOI: 10.15789/2220–7619–2018–1–7–18. [Nesterova I. V., Kolesnikova N. V., Chudilova G. A., Lomtatidze L. V., Kovaleva S. V., Yevglevsky A. A., Nguyen T. Z.L. A new look at neutrophilic granulocytes: rethinking old dogmas. (Part 2). Infection and immunity 2017, 7(3), 219–230. DOI: 10.15789/2220–7619–2018–1–7–18. Russian].</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Elghetany M. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis. 2002, 28 (2): 260–274. PMID12064921.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Garnache-Ottou F., Chaperot L., Biichle S., Ferrand C., Remy-Martin J. P., Deconinck E., de Tailly P. D., Bulabois B., Poulet J., Kuhlein E., Jacob M. C., Salaun V., Arock M., Drenou B., Schillinger F., Seilles E., Tiberghien P., Bensa J. C., Plumas J., Saas P. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 2005, 105(3), 1256–1264. DOI: 10.1182/blood-2004–06–2416.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hernandez-Caselles T., Martinez-Esparza M., Perez-Oliva A. B., Quintanilla-Cecconi A. M., Garcia-Alonso A., Alvarez-Lopez D. M., Garcia-Penarrubia P. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. Journal of Leukocyte Biology 2006, 79(1), 46–58. DOI: 10.1189/jlb.0205096.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Crocker P. R., Zhang J. New I-type lectins of the CD33- related siglec subgroup identifi ed through genomics. Biochemical Society Symposia 2002, 69; 83–94. DOI: 10.1042/bss0690083.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bandura D. R., Baranov V. I., Ornatsky O. I., Antonov A., Kinach R., Udong Lou X., Pavlov S., Vorobiev S., Dick J. E. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-fl ight mass spectrometry. Analytical Chemistry 2009, 81, 6813–6822. DOI: 10.1021/ac901049w.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ornatsky O., Bandura D., Baranov V., Nitz M., Winnik M. A., Tanner S. Highly multiparametric analysis by mass cytometry. J. Immunol. Methods 2010, 361(1–2), 1–20. DOI: 10.1016/j.jim.2010.07.002.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Schroder A. K., Uciechowski P., Fleischer D., Rink L. Crosslinking of CD66b on peripheral blood neutrophils mediates the release of interleukin-8 from intracellular storage. Hum. Immunol. 2006, 67(9), 676–682. DOI: 10.1016/j.humimm.2006.05.004.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mandruzzato S., Brandau S., Britten C. M., Bronte V., Damuzzo V., Gouttefangeas C., Maurer D., Ottensmeier C., van der Burg S. H., Welters M. J., Walter S. Toward harmonized phenotyping of human myeloidderived suppressor cells by fl ow cytometry: results from an interim study. Cancer Immunol. Immunother. 2016, 65(2), 161–169. DOI: 10.1007/s00262–015–1782–5.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zhang Y., Boesen C. C., Radaev S., Brooks A. G., Fridman W. H., Sautes-Fridman C., Sun P. D. Crystal structure of the extracellular domain of a human Fc?RIII”. Immunity. 2000, 13 (3), 387–95. DOI:10.1016/S1074–7613(00)00038–8.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Нестерова И. В. Препараты интерферона альфа в клинической практике: когда и как. Лечащий врач 2017, 9, 66–76. https://www.lvrach.ru/2017/9/ [Nesterova I. V. Interferon alfa preparations in clinical practice: when and how. Treatment doctor 2017, 9, 66–76. https://www.lvrach.ru/2017/9/. Russian].</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Brandacher G., Margreiter D., Fuchs D. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation. Curr. Drug Metab. 2007, 8(3), 273–282. PMID: 17430115.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sato T., Hongu T., Sakamoto M., Funakoshi Y., Kanaho Y. Molecular mechanisms of N-Formyl-Methionylleucyl- phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol. Cell Biol. 2013, 33(1), 136–145. DOI: 10.1128/MCB.00869–12.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schmidt T., Brodesser A., Schnitzler N., Gruger T., Brandenburg K., Zinserling J., Zundorf J. CD66b overexpression and loss of C5a receptors as surface markers for Staphylococcus aureus-induced neutrophil dysfunction. PLoS ONE2015, 10(7), e0132703. DOI: 10.1371/journal.pone.0132703.</mixed-citation></ref></ref-list></back></article>
